United Therapeutics Has Limited Downside Below $95 Level, Credit Suisse Says In Upgrade
April 03, 2018 at 16:05 PM EDT
Despite shares of United Therapeutics Corporation (NASDAQ: UTHR) being a consistent sell-side short amid mounting risks, a Credit ...